Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study.

Ribas A, Medina T, Kummar S, Amin A, Kalbasi A, Drabick JJ, Barve M, Daniels GA, Wong DJ, Schmidt EV, Candia AF, Coffman RL, Leung ACF, Janssen RS.

Cancer Discov. 2018 Oct;8(10):1250-1257. doi: 10.1158/2159-8290.CD-18-0280. Epub 2018 Aug 28.

PMID:
30154193
2.

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.

Jackson S, Lentino J, Kopp J, Murray L, Ellison W, Rhee M, Shockey G, Akella L, Erby K, Heyward WL, Janssen RS; HBV-23 Study Group.

Vaccine. 2018 Jan 29;36(5):668-674. doi: 10.1016/j.vaccine.2017.12.038. Epub 2017 Dec 27.

3.
5.

Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease.

Janssen RS, Mangoo-Karim R, Pergola PE, Girndt M, Namini H, Rahman S, Bennett SR, Heyward WL, Martin JT.

Vaccine. 2013 Nov 4;31(46):5306-13. doi: 10.1016/j.vaccine.2013.05.067. Epub 2013 May 30.

PMID:
23727422
6.

Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age.

Heyward WL, Kyle M, Blumenau J, Davis M, Reisinger K, Kabongo ML, Bennett S, Janssen RS, Namini H, Martin JT.

Vaccine. 2013 Nov 4;31(46):5300-5. doi: 10.1016/j.vaccine.2013.05.068. Epub 2013 May 30.

PMID:
23727002
7.

Epidemiology of HIV in the United States and Canada: current status and ongoing challenges.

Hall HI, Geduld J, Boulos D, Rhodes P, An Q, Mastro TD, Janssen RS, Archibald CP.

J Acquir Immune Defic Syndr. 2009 May 1;51 Suppl 1:S13-20. doi: 10.1097/QAI.0b013e3181a2639e.

PMID:
19384096
8.

Advancing HIV prevention demonstration projects: new strategies for a changing epidemic.

Heffelfinger JD, Sullivan PS, Branson BM, Mastro TD, Purcell DW, Griffiths SD, Romaguera RA, Janssen RS.

Public Health Rep. 2008 Nov-Dec;123 Suppl 3:5-15. No abstract available.

9.

Estimation of HIV incidence in the United States.

Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, Karon J, Brookmeyer R, Kaplan EH, McKenna MT, Janssen RS; HIV Incidence Surveillance Group.

JAMA. 2008 Aug 6;300(5):520-9. doi: 10.1001/jama.300.5.520.

10.

Implementing HIV screening.

Janssen RS.

Clin Infect Dis. 2007 Dec 15;45 Suppl 4:S226-31. doi: 10.1086/522542.

PMID:
18190291
11.

Partner counseling and referral services for HIV infection: new endorsement of an old approach.

Dooley SW Jr, Douglas JM Jr, Janssen RS.

Am J Prev Med. 2007 Aug;33(2 Suppl):S81-3. No abstract available.

PMID:
17675015
12.

Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach.

McNaghten AD, Wolfe MI, Onorato I, Nakashima AK, Valdiserri RO, Mokotoff E, Romaguera RA, Kroliczak A, Janssen RS, Sullivan PS.

PLoS One. 2007 Jun 20;2(6):e550.

13.

HIV testing: rationale for changing recommendations.

Janssen RS.

Top HIV Med. 2007 Feb-Mar;15(1):6-10.

14.

Public goods, private data: HIV and the history, ethics, and uses of identifiable public health information.

Fairchild AL, Gable L, Gostin LO, Bayer R, Sweeney P, Janssen RS.

Public Health Rep. 2007;122 Suppl 1:7-15. No abstract available.

15.

Progress toward implementation of integrated systems for surveillance of HIV infection and morbidity in the United States.

Sullivan PS, McKenna MT, Janssen RS.

Public Health Rep. 2007;122 Suppl 1:1-3. No abstract available.

16.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33; quiz CE1-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2007 Oct 26;56(42):1114.

17.

Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, Clark JE; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4.

18.
19.

Recent HIV testing among young men who have sex with men: correlates, contexts, and HIV seroconversion.

MacKellar DA, Valleroy LA, Anderson JE, Behel S, Secura GM, Bingham T, Celentano DD, Koblin BA, LaLota M, Shehan D, Thiede H, Torian LV, Janssen RS.

Sex Transm Dis. 2006 Mar;33(3):183-92.

PMID:
16508526
20.

CDC: HIV prevention efforts.

Janssen RS, McKenna MT.

Health Aff (Millwood). 2005 Nov-Dec;24(6):1683; author reply 1683-4. No abstract available.

PMID:
16284044
21.
22.

Unrecognized HIV infection, risk behaviors, and perceptions of risk among young men who have sex with men: opportunities for advancing HIV prevention in the third decade of HIV/AIDS.

MacKellar DA, Valleroy LA, Secura GM, Behel S, Bingham T, Celentano DD, Koblin BA, Lalota M, McFarland W, Shehan D, Thiede H, Torian LV, Janssen RS; Young Men's Survey Study Group.

J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):603-14.

PMID:
15793373
23.

HIV prevention in the United States: increasing emphasis on working with those living with HIV.

Janssen RS, Valdiserri RO.

J Acquir Immune Defic Syndr. 2004 Oct 1;37 Suppl 2:S119-21. No abstract available.

PMID:
15385908
24.

Aligning budget with U.S. National HIV prevention priorities.

Valdiserri RO, Ogden LO, Janssen RS, Onorato I, Martin T.

J Public Health Manag Pract. 2004 Mar-Apr;10(2):140-7.

PMID:
14967981
25.

Classification of transmission risk in the national HIV/AIDS surveillance system.

Lee LM, McKenna MT, Janssen RS.

Public Health Rep. 2003 Sep-Oct;118(5):400-7.

26.

Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.

Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV.

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):625-34.

PMID:
12902808
27.

Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection.

Rawal BD, Degula A, Lebedeva L, Janssen RS, Hecht FM, Sheppard HW, Busch MP.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):349-55.

PMID:
12843746
28.

Protease inhibitors and cardiovascular outcomes in patients with HIV-1.

Holmberg SD, Moorman AC, Williamson JM, Tong TC, Ward DJ, Wood KC, Greenberg AE, Janssen RS; HIV Outpatient Study (HOPS) investigators.

Lancet. 2002 Nov 30;360(9347):1747-8.

PMID:
12480430
29.

An unequal epidemic in an unequal world.

De Cock KM, Janssen RS.

JAMA. 2002 Jul 10;288(2):236-8. No abstract available.

30.

HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States.

Weinstock H, Dale M, Gwinn M, Satten GA, Kothe D, Mei J, Royalty J, Linley L, Fridlund C, Parekh B, Rawal BD, Busch MP, Janssen RS.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):478-83.

PMID:
11981364
31.

Repeat HIV testing, risk behaviors, and HIV seroconversion among young men who have sex with men: a call to monitor and improve the practice of prevention.

MacKellar DA, Valleroy LA, Secura GM, Bartholow BN, McFarland W, Shehan D, Ford W, LaLota M, Celentano DD, Koblin BA, Torian LV, Perdue TE, Janssen RS; Young Men's Survey Study Group.

J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):76-85.

PMID:
11782594
32.

The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals.

Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM.

Am J Public Health. 2001 Jul;91(7):1019-24.

33.

Two decades after vaccine license: hepatitis B immunization and infection among young men who have sex with men.

MacKellar DA, Valleroy LA, Secura GM, McFarland W, Shehan D, Ford W, LaLota M, Celentano DD, Koblin BA, Torian LV, Thiede H, Janssen RS; Young Men's Survey Study Group.

Am J Public Health. 2001 Jun;91(6):965-71.

34.

The context of HIV/AIDS surveillance.

Valdiserri RO, Janssen RS, Buehler JW, Fleming PL.

J Acquir Immune Defic Syndr. 2000 Dec 15;25 Suppl 2:S97-104. Review.

PMID:
11256740
35.

Gender differences in sexual behaviors and factors associated with nonuse of condoms among homeless and runaway youths.

MacKellar DA, Valleroy LA, Hoffmann JP, Glebatis D, Lalota M, McFarland W, Westerholm J, Janssen RS.

AIDS Educ Prev. 2000 Dec;12(6):477-91.

PMID:
11220501
36.

Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San Francisco.

McFarland W, Busch MP, Kellogg TA, Rawal BD, Satten GA, Katz MH, Dilley J, Janssen RS.

J Acquir Immune Defic Syndr. 1999 Dec 15;22(5):484-9.

PMID:
10961610
37.

Tracking the HIV epidemic: current issues, future challenges.

Fleming PL, Wortley PM, Karon JM, DeCock KM, Janssen RS.

Am J Public Health. 2000 Jul;90(7):1037-41. Review.

38.

HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group.

Valleroy LA, MacKellar DA, Karon JM, Rosen DH, McFarland W, Shehan DA, Stoyanoff SR, LaLota M, Celentano DD, Koblin BA, Thiede H, Katz MH, Torian LV, Janssen RS.

JAMA. 2000 Jul 12;284(2):198-204.

PMID:
10889593
39.

Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection.

Holman RC, Török TJ, Belay ED, Janssen RS, Schonberger LB.

Neuroepidemiology. 1998;17(6):303-9.

PMID:
9778596
40.

HIV infection in disadvantaged out-of-school youth: prevalence for U.S. Job Corps entrants, 1990 through 1996.

Valleroy LA, MacKellar DA, Karon JM, Janssen RS, Hayman CR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):67-73.

PMID:
9732072
41.

New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.

Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch MP.

JAMA. 1998 Jul 1;280(1):42-8. Erratum in: JAMA 1999 May 26;281(20):1893.

PMID:
9660362
42.

Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients.

Chin KM, Sidhu JS, Janssen RS, Weber JT.

Obstet Gynecol. 1998 Jul;92(1):83-7.

PMID:
9649099
43.
44.

Human immunodeficiency virus infection and stroke in young patients.

Qureshi AI, Janssen RS, Karon JM, Weissman JP, Akbar MS, Safdar K, Frankel MR.

Arch Neurol. 1997 Sep;54(9):1150-3.

PMID:
9311359
45.

Serologic test for syphilis as a surrogate marker for human immunodeficiency virus infection among United States blood donors.

Herrera GA, Lackritz EM, Janssen RS, Raimondi VP, Dodd RY, Aberle-Grasse J, Petersen LR.

Transfusion. 1997 Aug;37(8):836-40.

PMID:
9280329
46.

Intracerebral hemorrhage in blacks. Risk factors, subtypes, and outcome.

Qureshi AI, Suri MA, Safdar K, Ottenlips JR, Janssen RS, Frankel MR.

Stroke. 1997 May;28(5):961-4.

PMID:
9158633
47.

Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men.

Katz MH, Hsu L, Wong E, Liska S, Anderson L, Janssen RS.

J Infect Dis. 1997 May;175(5):1225-9.

PMID:
9129091
48.

Crack cocaine use and stroke in young patients.

Qureshi AI, Akbar MS, Czander E, Safdar K, Janssen RS, Frankel MR.

Neurology. 1997 Feb;48(2):341-5.

PMID:
9040718
49.

Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.

Lackritz EM, Satten GA, Aberle-Grasse J, Dodd RY, Raimondi VP, Janssen RS, Lewis WF, Notari EP 4th, Petersen LR.

N Engl J Med. 1995 Dec 28;333(26):1721-5.

50.

Stroke in young black patients. Risk factors, subtypes, and prognosis.

Qureshi AI, Safdar K, Patel M, Janssen RS, Frankel MR.

Stroke. 1995 Nov;26(11):1995-8.

PMID:
7482637

Supplemental Content

Loading ...
Support Center